LAURA DOUGHERTY: Open Payments
NPI 1316913387 · CLACKAMAS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 36 payments from 12 companies in 2025. Trend: 2023 $892 · 2024 $1,166 · 2025 $941
Food & beverage: $846Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $315 |
| Janssen Biotech, Inc. | 8 | $213 |
| Galderma Laboratories, L.P. | 6 | $135 |
| UCB, Inc. | 2 | $59 |
| ABBVIE INC. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $41 |
| GENZYME CORPORATION | 1 | $40 |
| Incyte Corporation | 2 | $34 |
| BioWound Solutions, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, RINVOQ, ILUMYA, OPZELURA, AKLIEF.
Industry payments across OR — which companies pay providers there.
